Retreatment of Chronic Hepatitis C Infection with Telaprevir : Turkey Experience.

Pekgoz M., GÜREL S., KIYICI M., GÜLTEN M., Dolar E., NAK S. G.

Acta gastro-enterologica Belgica, vol.79, no.1, pp.18-22, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 79 Issue: 1
  • Publication Date: 2016
  • Journal Name: Acta gastro-enterologica Belgica
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Page Numbers: pp.18-22
  • Keywords: Hepatitis C, Telaprevir, triple treatment, sustained virologic response, RIBAVIRIN, PEGINTERFERON, ALPHA-2A
  • Bursa Uludag University Affiliated: Yes


Background/Aims : Patients with genotype 1 chronic hepatitis C virus (HCV) who do not have a sustained virologic response to therapy with peginterferon alfa and ribavirin have a low likelihood of success with retreatment.